BioRestorative Therapies, Inc. (NASDAQ:BRTX) Sees Significant Increase in Short Interest

BioRestorative Therapies, Inc. (NASDAQ:BRTX) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 130,200 shares, a growth of 19.4% from the December 31st total of 109,000 shares. Currently, 2.6% of the company’s shares are sold short. Based on an average daily volume of 64,600 shares, the short-interest ratio is presently 2.0 days.

BioRestorative Therapies Trading Down 0.8 %

BioRestorative Therapies stock traded down $0.02 during mid-day trading on Monday, hitting $2.36. The company’s stock had a trading volume of 66,042 shares, compared to its average volume of 72,621. BioRestorative Therapies has a 1 year low of $1.03 and a 1 year high of $3.67. The firm has a market capitalization of $16.33 million, a PE ratio of -1.54 and a beta of 62.64. The stock’s fifty day moving average is $1.70 and its two-hundred day moving average is $1.63.

BioRestorative Therapies (NASDAQ:BRTX) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.22. BioRestorative Therapies had a negative return on equity of 98.49% and a negative net margin of 2,697.08%. The firm had revenue of $0.23 million during the quarter, compared to the consensus estimate of $0.30 million. On average, equities analysts expect that BioRestorative Therapies will post -1.43 EPS for the current fiscal year.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.